4/A//SEC Filing
Leahy Emer 4/A
Accession 0001213900-24-030962
CIK 0001841330other
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 9:45 PM ET
Size
6.4 KB
Accession
0001213900-24-030962
Insider Transaction Report
Form 4/AAmended
Leahy Emer
Director
Transactions
- Award
Stock Option (right to buy)
2024-03-01+7,500→ 7,500 totalExercise: $8.13Exp: 2034-02-28→ Common Stock (7,500 underlying)
Footnotes (2)
- [F1]The sole purpose of this Form 4/A is to correct the exercise price, which was previously reported erroneously as $8.34 per share. The correct exercise price, based upon the closing price of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), on March 1, 2024, was $8.13 per share.
- [F2]The option award (the "Option") was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan. The shares of Common Stock underlying the Option will vest at the rate of 33% upon the one-year anniversary of the date of grant and 33% on each successive one-year anniversary thereafter; provided, that the Reporting Person remains a director of the Issuer through such vesting date.
Documents
Issuer
Pasithea Therapeutics Corp.
CIK 0001841330
Entity typeother
Related Parties
1- filerCIK 0001875180
Filing Metadata
- Form type
- 4/A
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 9:45 PM ET
- Size
- 6.4 KB